As of Nov 22
| +4.16 / +2.44%|
The 19 analysts offering 12-month price forecasts for Allergan have a median target of 235.00, with a high estimate of 280.00 and a low estimate of 191.00. The median estimate represents a +34.42% increase from the last price of 174.83.
The current consensus among 23 polled investment analysts is to Buy stock in Allergan. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.